ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2185 entries already.
Entries by Thomas Gabrielczyk
Is AMR the next, but hidden, crisis?
With the coronavirus pandemic mounting, experts are warning of AMR as being the next, hidden crisis.
Researchers reconstruct SARS-CoV-2 evolution
British researchers have tabled a phylogenetic tree showing different subtypes of SARS-CoV-2 developed in Asia, Europe and the US.
COVID-19: Solnatide approved for compassionate use
Austrian COVID-19 patients with severe lung dysfunction for the first time have a treatment option within a compassionate use program for Apeptico’s solnatide.
GE renamed Cytiva upon take-over by Danaher
Making opoids more effective pain killers
Low intrinsic efficacy can explain the reduced side effects of new agonists of the m-opioid receptor a British-Australian reseach team reports.
Apeptico gets EU grant for COVID-19 drug
Austrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients
CHMP greenlights Novartis’ Zolgensma
The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
New resource models human metabolism
Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Novacyt inks contract on Covid-19 diagnostics
Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.